Cbdmd, Inc. · AMEX:YCBD
Cbdmd — Investor Presentation (May 2019)
38 slides from Cbdmd's investor presentation, May 10, 2019
Slide 1: cbdMD: Powered by Nature. Enhanced by Science.
cobdMD POWERED BY NATURE. ENHANCED BY SCIENCE. NYSE: American: YCBD
Slide 2: Forward-Looking Statements
FORWARD-LOOKING STATEMENTS ‘This presentation contains certain forwardookng statements that are based upon current expectations and Involve certain risks and uncertainties within the meaning ofthe US. Private Secures Utigation Refoem Ac of 1995, Such forward ooking statements canbe identified by the
Slide 3: An Industry Leader with the Highest Standard
AN INDUSTRY LEADER WITH THE HIGHEST STANDARD
Slide 4: What Is CBD?
Slide 5: Farm Bill / Legalization
Slide 6: Robust Marketing Campaign: Times Square
Slide 7: Commitment to Restful Sleep, Relieving Stress, Relaxation and Focus
Commitment to Commitment to Commitment to Restful Sleep Relieving Stress Relaxation and Focus ‘oman rem ers nt th pt a Sy a em Prien ilewmtenacricc Ne Sateen tm ay ssa aha manana ne: ‘histceete am mee ery tt ge energie ah ne ay ga a
Slide 8: 100% U.S. Grown; Hybrid Broad Spectrum Manufacturing Process
100% U.S. GROWN (ur CBD comes from organically HYBRID BROAD SPECTRUM \ MANUFACTURING PROCESS With our innovative hybrid manufacturing other beneficial compounds
Slide 9: Enhanced by Science
NCED BY SCIENCE.
Slide 10: U.S. CBD market could approach $16B by 2025
By 2025, it is estimated that the U.S. CBD market could approach $16B (from $600M -$28 in 2018)
Slide 11: CBD Beauty and Fitness
cba BEAUTY FITNESS. 10
Slide 12: Do You Use CBD as a Supplement?
DO YOU USE CBD AS A SUPPLEMENT?
Slide 13: CBD Topicals Expected to Dominate Industry Sales
CBD TOPICALS EXPECTED TO DOMINATE INDUSTRY SALES cbdMD U.S. Addressable Topical Market U.S. CBD Topicals Market $1280 si280 i280 ae 3158 '$500M 2018 20196 20206 US Tp category Ceertes $18 Revere ‘Source: Company Reports and Cowen and Company ‘oD Topas Cold A150 Matin? Yeas Source Comen and Company 2
Slide 14: Key Demographics
ze i H i H i aL KEY DEMOGRAPHICS f
Slide 15: Manufacturing + R&D and Distribution
MANUFACTURING + R&D: ‘cbdMD manufactures products utilizing a hybrid broad spectrum, process in a privately-owned, state-of-the-art facility in Charlotte, NC. Each batch is tested by an independent third-party laboratory to onsure the absolute highest standards of quality control. ‘Current Square Fo
Slide 16: cbdMD
cbdMp
Slide 17: December 2018 Working Capital
cba DECEMBER 3 2018 WORKING CAPITAL TOTAL CURRENT ASSETS : TOTAL CURRENT LIABILITIES SHAREHOLDER'S EQUITY
Slide 18: Powerful Brand Building & Executive Team
POWERFUL BRAND BUILDING & EXECUTIVE TEAM LEADERSHIP TEAM BOARD OF DIRECTORS
Slide 19: Capitalization April 23, 2019 and Share Ownership
cbdMo CAPITALIZATION APRIL 23, 2019 SHARE OWNERSHIP 25,420,356 Punlc Fost S39" Management & thadere caer ‘pes 1625000 share sud for tps Cre Based Detopment 18
Slide 20: Robust Marketing Campaign
Slide 21: National Hemp Day Founder
cba National: August National Hemp Day February FOUNDER & CREATOR OF NATION: EMP DAY
Slide 22: Sleep Naturally. Wake Refreshed.
cba SLEEP NATURALLY. WAKE REFRESHED. cbdMD
Slide 23: Introducing cbdMD
INTRODUCING @EbdMD
Slide 24: UFC/MMA Athletes
Slide 25: Skateboarding: Ryan Sheckler
Slide 26: Motocross Athletes
Slide 27: Nate Adams: X Games Medals
Slide 28: Wellness
ure Werrcus
Slide 29: RallyCross Athletes
Slide 30: Body Building: James Flex Lewis
Slide 31: Surfing Athletes
Slide 32: World Wake Association Athletes
Slide 33: PGA Golf
Slide 34: Official CBD Partner of the BIG3
OFFICIAL CBD PARTNER OF THE BIG3
Slide 35: cbdMD: Amanda Cerny
cbdMD AMANDA CERNY
Slide 36: cbdMD Pets
cbhdMD PETS LIL BUB TWO-FACE CAT @2mr G3MF Oar
Slide 37: Summary of Investment Highlights
SUMMARY OF INVESTMENT HIGHLIGHTS cbdMD First Amarican CBD company to be traded on a national exchange (NYSE American) US. CBD market estimated to reach $16 billion by 2025 100% organically grown US. hemp, free ofall synthetic pesticides Innovative hybrid broad spectrum manufacturing process preserve
Slide 38: Slide 38